GRETO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.343
EU - Europa 4.855
AS - Asia 4.073
SA - Sud America 459
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 96
OC - Oceania 53
Totale 18.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.187
RU - Federazione Russa 1.842
CN - Cina 1.190
SG - Singapore 1.190
IT - Italia 1.049
PL - Polonia 570
HK - Hong Kong 550
BR - Brasile 364
IE - Irlanda 356
VN - Vietnam 332
KR - Corea 331
SE - Svezia 251
DE - Germania 220
FR - Francia 194
FI - Finlandia 129
IN - India 129
GB - Regno Unito 97
CA - Canada 88
JO - Giordania 83
BD - Bangladesh 67
AU - Australia 52
AR - Argentina 41
ID - Indonesia 35
JP - Giappone 32
ES - Italia 30
IQ - Iraq 28
MX - Messico 27
NL - Olanda 25
CI - Costa d'Avorio 23
UA - Ucraina 18
ZA - Sudafrica 18
TR - Turchia 16
CH - Svizzera 15
BE - Belgio 13
EC - Ecuador 13
CZ - Repubblica Ceca 11
LT - Lituania 11
PK - Pakistan 11
MA - Marocco 10
SA - Arabia Saudita 10
VE - Venezuela 10
CL - Cile 9
NG - Nigeria 9
PH - Filippine 9
UZ - Uzbekistan 9
CO - Colombia 8
JM - Giamaica 8
KE - Kenya 8
KZ - Kazakistan 7
PE - Perù 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
EG - Egitto 6
RO - Romania 6
AT - Austria 5
AZ - Azerbaigian 5
BJ - Benin 5
SC - Seychelles 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
LB - Libano 4
PY - Paraguay 4
SV - El Salvador 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
NP - Nepal 3
PA - Panama 3
UY - Uruguay 3
BG - Bulgaria 2
BY - Bielorussia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MY - Malesia 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 17.876
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.520
Ashburn 1.151
Singapore 873
Fairfield 637
Warsaw 565
Hong Kong 475
Chandler 380
Dublin 354
San Jose 346
Seoul 330
Seattle 297
Woodbridge 277
Cambridge 273
Hefei 265
Houston 239
Beijing 216
Wilmington 212
Milan 180
Los Angeles 137
Dearborn 131
Council Bluffs 125
Munich 120
Lawrence 119
Buffalo 113
Florence 112
Ho Chi Minh City 111
Altamura 108
New York 99
Rome 96
Princeton 90
Moscow 84
The Dalles 84
Lauterbourg 76
Paris 76
Ann Arbor 75
Hanoi 63
Shanghai 58
Mumbai 57
Boston 54
Helsinki 53
Kent 53
Guangzhou 49
Melbourne 47
Clifton 45
Medford 45
San Diego 41
Frankfurt am Main 38
Dallas 37
São Paulo 36
Turku 34
Boardman 28
Orem 28
London 27
Tokyo 27
Brooklyn 26
Jakarta 24
Abidjan 23
Redondo Beach 23
Toronto 23
Naples 22
Haiphong 20
Montreal 20
Falls Church 18
Figino 18
West Jordan 18
Bengaluru 17
Stockholm 17
Chicago 16
San Francisco 16
Bologna 15
Chennai 15
Ningbo 14
Phoenix 14
Turin 14
Barcelona 13
Brussels 13
Miano 13
Pune 13
Baghdad 12
Belo Horizonte 12
Bern 12
Lappeenranta 12
Buenos Aires 11
Dong Ket 11
Jacksonville 11
Brescia 10
Da Nang 10
Denver 10
Genoa 10
Mexico City 10
Poplar 10
Tianjin 10
Yubileyny 10
Biên Hòa 9
Johannesburg 9
Nanjing 9
Norwalk 9
Palermo 9
Rio de Janeiro 9
Tashkent 9
Totale 11.815
Salva come PNG Salva come JPEG
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 402
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 324
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 297
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 282
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 270
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 251
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 247
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 240
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 237
Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience 234
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 234
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 226
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 222
Influence of age and subtype in outcome of operable liposarcoma 220
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 219
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 219
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 218
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 218
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 216
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 212
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 211
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 211
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 210
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 208
Methodological approach to create an atlas using a commercial auto-contouring software 206
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 201
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 200
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 199
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 199
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 197
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 197
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 197
Radiotherapy in the age of cancer immunology: Current concepts and future developments 196
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 195
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 195
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 194
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 193
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 192
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 192
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 191
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO) 191
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 190
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting 189
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. 189
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 188
Leiomyosarcoma: Clinicopathological study and retrospective analysis of prognostic factors in a series of 100 patients 187
TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation 187
Intercomparison Study On Small Field Output Factor Measurements 185
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 184
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 184
Impact of COVID-19 on workload burden of a complex radiotherapy facility 184
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 183
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 181
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 180
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 179
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 178
Regorafenib in glioblastoma recurrence: A case report 178
Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution 176
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 173
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 172
Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma 171
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 170
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 170
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 167
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 166
GammaTools: A modular multifunction phantom for quality assurance in GammaKnife treatments 165
Clinical features, prognostic factors and outcome in a series of 29 extra-skeletal Ewing Sarcoma. Adequate margins and surgery-radiotherapy association improve overall survival 164
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 162
Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant 162
PO-0873: 2D pixelated diamond detector for patient QA in advanced radiotherapy treatments 162
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 160
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 159
Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature 157
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 156
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 155
Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors 155
Prognostic impact of nodal relapse in definitive prostate-only irradiation 151
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 144
Treatment options in femoral radiation fractures following soft tissue sarcoma: Incidence, risk factors, failures and flowchart of treatment 143
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 143
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 141
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network 140
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 140
Brief report: pediatric high-grade gliomas treated with vinorelbine and valproic acid added to temozolomide 137
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach. 133
Single-fraction radiotherapy (SFRT) for bone metastases: Patient selection and perspectives 124
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 124
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 116
CONFORMAL RADIOTHERAPY (3DCRT) TO ATTEMPT RADICAL plus CHEMOTHERAPY +/- SURGERY IN THE TREATMENT OF EWING'S SARCOMA (EWS) BASED ON THE PELVIC AREA 116
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 114
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 113
Radiation treatment for adult rare cancers: Oldest and newest indication 112
Neoadjuvant treatment of soft tissue sarcoma: A single center experience 112
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 109
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 108
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group 105
Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors 102
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914) 70
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma 42
MRI-based radiomic analysis for grading myxoid liposarcoma: a multisequence retrospective study 38
Totale 18.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022521 0 26 42 25 20 28 16 54 31 23 86 170
2022/20231.643 129 369 87 74 115 278 209 111 189 3 56 23
2023/2024862 31 63 99 33 66 131 36 229 15 54 76 29
2024/20255.027 194 485 293 828 1.379 550 70 311 246 155 207 309
2025/20266.139 645 765 550 515 725 222 719 304 410 443 200 641
2026/2027522 220 302 0 0 0 0 0 0 0 0 0 0
Totale 18.024